entertainment -WSS

entertainment

author：fashion 2025-09-27 19:28:45 - browse：973

A DNA helix, with dollar banknotes covering its strands, collapses next to another DNA helix with dollar banknotes strands — coverage from STAT — Adobe

The closely watched gene-editing startup Prime Medicine is embroiled in a multimillion-dollar dispute with another biotech it partnered with to develop a potentially powerful new form of genome editing.

Prime and Myeloid Therapeutics, a startup co-founded by Pulitzer Prize-winning writer and cancer biologist Siddhartha Mukherjee, have filed competing arbitration claims over a deal they signed in March 2022.

Prime, spun out of the lab of Broad Institute biochemist David Liu, was built on technology for making small insertions, deletions, and single-letter changes in DNA. In theory, prime editing allows researchers to tackle the vast majority of disease-causing mutations, and the first treatments are already being readied for clinical trials. But it’s a poor fit in cases where hundreds or even thousands of different mutations in a long gene cause the same diseases, such as cystic fibrosis or Duchenne muscular dystrophy.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： How to fix the rural physician shortage in the U.S.

hotspot

focus

WSS

My daughter's legacy lives on through her writing, phage therapy

My daughter's legacy lives on through her writing, phage therapy

Coercive sterilizations revealed by STAT prompt outrage

Reanimated hearts work just as well for transplants, study finds

Sea level rise could wash away turtle breeding grounds around the world, researchers say

Cheap, fast test for Zika and dengue could cost just $1

hotspot

entertainment

entertainment

Medical records are filled with copy

New report analyzes digital physical therapy solutions' effectiveness

23andMe had bad news about my health. I wish a person had delivered it

Medical device trials still don't enroll enough women, study finds

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

State Dept. review finds Biden bears some blame for Afghanistan failures

Eli Lilly’s Mounjaro succeeds in second weight

Medicare proposal to cover medical devices draws a mixed reaction

Curing rare childhood diseases will falter unless Congress steps up

knowledge

'Essentially witchcraft:' A former naturopath takes on the field

Health care court cases: Humana, Sutter, Novant

How to fix the rural physician shortage in the U.S.

Senate panel passes drug pricing bills, but drops one PBM reform

'Essentially witchcraft:' A former naturopath takes on the field

Xenotransplantation trials will require adjusting expectations, experts say

hotspot

hotspot

focus

explore